Skip to main content
. 2009 Jul 28;11(9):475–482. doi: 10.1111/j.1751-7176.2009.00159.x

Figure 3.

Figure 3

Achievement of blood pressure (BP) targets by treatment regimen. Data represent all patients who were exposed to a particular treatment regimen throughout the duration of the open‐label extension, regardless of whether they remained on the regimen or were titrated to another. All drug concentrations are mg/d. AML indicates amlodipine; HCTZ, hydrochlorothiazide; OM, olmesartan medoxomil.